Kuehn Law Encourages Investors of Merck & Co., Inc. to Contact Law Firm Newsfile Corp
Market data is delayed by at least 15 minutes.
    Latest Story Top Stories on MRK
    Kuehn Law Encourages Investors of Merck & Co., Inc. to Contact Law Firm
    4:48p ET May 1 '25 Newsfile Corp

    New York, New York--(Newsfile Corp. - May 1, 2025) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Merck & Co., Inc. (NYSE: MRK) breached their fiduciary duties to shareholders.

    According to a federal securities lawsuit, Insiders at Merck caused the company to misrepresent or fail to disclose material information concerning Merck's expected revenue of $11 billion from sales of Gardasil by 2030, including, among other things, confidence in Merck's purported ability to utilize successful consumer activation and education efforts on the benefits of Gardasil in order to drive demand and capitalize on eligible populations for vaccination, resulting in confidently optimistic reports and forecasts of Gardasil's growth in China.

    If you currently own MRK and purchased prior to February 3, 2022 please contact Justin Kuehn, Esq. here, by email at justin@kuehn.lawor call (833) 672-0814. Kuehn Law pays all case costs and does not charge its investor clients.Shareholders should contact the firm immediately as there may be limited time to enforce your rights.

    Why Your Participation Matters:

    As a shareholder your voice matters, and by getting involved, you contribute to the integrity and fairness of the financial markets. Your investment. Your voice. Your future.™

    For additional information, please visit Shareholder Derivative Litigation - Kuehn Law.

    Attorney advertising. Prior results do not guarantee similar outcomes.

    Contacts:Kuehn Law, PLLCJustin Kuehn, Esq.53 Hill Street, Suite 605 Southampton, NY 11968justin@kuehn.law(833) 672-0814

    To view the source version of this press release, please visit https://www.newsfilecorp.com/release/250518

    COMTEX_465120906/2523/2025-05-01T16:48:41

    MRK Investors Have Final Opportunity Today to Lead Merck & Co., Inc. ...
    11:55p ET April 13 '25 PR Newswire
    MRK Deadline Tomorrow: MRK Investors Have Opportunity to Lead Merck &...
    1:38p ET April 13 '25 PR Newswire
    DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of...
    6:49p ET April 7 '25 Newsfile Corp
    MRK Deadline: MRK Purchasers with Losses in Excess of $100K Have Oppo...
    3:55p ET April 7 '25 PR Newswire

    Market data provided by News provided by